Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-09

Clinical Trial Update: Efficacy And Safety Of Illumination Dose Reduction In Red Light Photodynamic Therapy For Actinic Keratoses [NA]

View source ↗

Summary

Clinical trial update on reducing illumination dose in red-light photodynamic therapy for actinic keratosis to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Actinic Keratoses | NA | Status: NOT_YET_RECRUITING